Satellos Bioscience Inc ICOTF

Primary Symbol: T.MSCL Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).

TSX:MSCL - Post by User

Satellos Bioscience Inc

<< Previous

Bullboard Posts

Next >>

Post by Frank11on Jan 04, 2019 10:54am

117 Views

Post# 29186126

bids

ICO

0.0

Open	0.065
Day High	0.08
Day Low	0.065
Previous Close	0.065
Average Volume	163,560

Level 2 Quote

Orders/Shares	Bid Price	Ask Price	Shares/Orders
5 / 147,000	0.075	0.08	88,000 / 5
9 / 1,143,000	0.07	0.085	73,000 / 5
4 / 143,000	0.065	0.09	132,000 / 4
6 / 215,000	0.06	0.095	102,000 / 4
6 / 348,000	0.055	0.10	170,000 / 5
8 / 357,000	0.05	0.11	44,000 / 3
8 / 381,000	0.045	0.115	15,000 / 1
3 / 40,000	0.04	0.12	34,000 / 2
3 / 86,000	0.035	0.125	165,000 / 3
4 / 907,000	0.03	0.13	51,000 / 2